Pfizer’s stock suffers as Q2 results and Mylan deal fail to impress Wall Street
Pfizer Inc.’s (NYSE: PFE) shares continue to trade in red after the company narrowly missed revenue estimates for...
Expert equity analysis, earnings previews, and data-driven market research.
Pfizer Inc.’s (NYSE: PFE) shares continue to trade in red after the company narrowly missed revenue estimates for...
Celgene Corporation (NASDAQ: CELG) reported a 50% jump in earnings for the second quarter of 2019 helped by...
Grubhub (NYSE: GRUB) stock price dropped over 7% before the bell as the second-quarter earnings failed to beat...
Shares of pharmaceutical giant Merck (NYSE: MRK) rose 3% before the market hours on Tuesday after the company...
Altria Group’s (NYSE: MO) Q2 earnings fell short by 1 cent from the analysts’ estimates. However, revenue topped...
Corning Incorporated (NYSE: GLW) reported a 88% dip in earnings for the second quarter of 2019 due to...
The Procter & Gamble Company (NYSE: PG) surpassed market expectations for revenue and earnings in the fourth quarter...
Eli Lilly and Company (NYSE: LLY) swung to a profit in the second quarter of 2019 from a...
AK Steel (NASDAQ: AKS) reported 17% growth in second-quarter earnings to 21 cents per share, compared to 5...
Fast food chain McDonald’s Corporation (NYSE: MCD) reported flat revenues for the second quarter. Earnings increased, helped by...
AbbVie’s (NYSE: ABBV) earnings and revenue for the second quarter of 2019 surpassed Wall Street’s estimates. AbbVie reported...
Phillips 66 (NYSE: PSX) reported a 6% increase in earnings for the second quarter of 2019 helped by...